Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04312880 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tranexamic Acid Infusion During Elective Spine Surgery

StatusEnrolling by Invitation
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 12, 2020 (before its estimated January 1, 2021 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
Tranexamic acid (TXA) is an agent that has been shown to be safe and effective to reduce blood loss in surgical procedures. The purpose of the study is to assess the effect of transexamic on elective decompressive lumbar spine surgery with and without fusion.
Trial Details
NCT Number NCT04312880
Lead Sponsor Albany Medical College
Conditions
(from sponsor)		 Spine Surgery
Enrollment 65 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov